Kinetic analysis of chlorpropamide dissolution from solid dispersions

被引:29
作者
Barzegar-Jalali, Mohammad [1 ]
Dastmalchi, Siavoush
机构
[1] Tabriz Univ Med Sci, Dept Pharmaceut, Sch Pharm, Tabriz 51664, Iran
[2] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz 51664, Iran
[3] Tabriz Univ Med Sci, Dept Med Chem, Sch Pharm, Tabriz 51664, Iran
[4] Tabriz Univ Med Sci, Biotechnol Res Ctr, Tabriz 51664, Iran
关键词
chlorpropamide; solvent deposition; solid dispersion; dissolution kinetics; reciprocal powered time model;
D O I
10.1080/03639040600762636
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Solid dispersions (SDs) of chlorpropamide were prepared by the solvent deposition technique using two grades of microcrystalline cellulose as carrier materials with different ratios of drug to carrier. The dissolution rate of chlorpropmide from the SDs was carried out at two physiological pH values of 1.1 and 7.25 simulating gastric and intestinal environments. The dissolution was dependent on the grade, the ratio of drug to carrier and pH. The higher dissolution was observed for more hydrophilic grade of the carrier as well as the higher ratio of carrier to drug. At the higher pH the drug dissolved much faster than the lower pH. X-ray diffraction showed some reduced drug crystallinity in SDs whereas infrared spectroscopy revealed no drug interactions with solvent and the carriers. The enhanced dissolution was attributed to the reduced drug crystallinity, decreased particle size, increased wettability and reduced aggregation of the hydrophobic drug particles. A novel model denoted as reciprocal powered time model with its theoretical justification was employed to analyze the dissolution data and proved to be superior to commonly used models for the analysis of the data. There was a quantitative relation between the model parameter and the ratio of carrier to drug which could be of value in dissolution rate prediction.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 19 条
  • [1] Enhancement of dissolution rate and anti-inflammatory effects of piroxicam using solvent deposition technique
    Barzegar-Jalali, M
    Maleki, N
    Garjani, A
    Khandar, AA
    Haji-Hosseinloo, M
    Jabbari, R
    Dastmalchi, S
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (06) : 681 - 686
  • [2] BATENHOST R L, 1982, Clinical Pharmacy, V1, P58
  • [3] Modeling and comparison of dissolution profiles
    Costa, P
    Manuel, J
    Lobo, S
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) : 123 - 133
  • [4] Dastmalchi S, 2005, J PHARM PHARM SCI, V8, P175
  • [5] DESHPANDE AV, 1985, PHARMAZIE, V40, P496
  • [6] DESHPANDE AV, 1983, PHARMAZIE, V38, P539
  • [7] EFFECT OF DIFFERENT GRADES OF POLYVINYLPYRROLIDONE ON DISSOLUTION RATE OF CHLORPROPAMIDE AND ITS ABSORPTION THROUGH RAT STOMACH
    DESHPANDE, AV
    AGRAWAL, DK
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1984, 10 (10) : 1725 - 1736
  • [8] SIMILARITIES IN THE RELEASE RATES OF DIFFERENT DRUGS FROM POLYETHYLENE-GLYCOL 6000 SOLID DISPERSIONS
    DUBOIS, JL
    FORD, JL
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (07) : 494 - 495
  • [9] BIOAVAILABILITY OF CHLORPROPAMIDE
    EVANS, M
    GLASS, RC
    MITCHARD, M
    MUNDAY, BM
    YATES, R
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (01) : 101 - 105
  • [10] EFFECT OF COMPOSITION AND AGING ON DISSOLUTION RATES OF CHLORPROPAMIDE-UREA SOLID DISPERSIONS
    FORD, JL
    RUBINSTEIN, MH
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (11) : 688 - 694